4//SEC Filing
MGI PHARMA INC 4
Accession 0001181431-05-055437
CIK 0000702131operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 11:37 AM ET
Size
13.7 KB
Accession
0001181431-05-055437
Insider Transaction Report
Form 4
MGI PHARMA INCMOGN
Loukas Eric P
Sr VP, Gen Counsel & Secy
Transactions
- Award
Common Stock
2005-10-03+2,000→ 5,500 total
Holdings
- 30,000
Employee Stock Option - Right to Buy
Exercise: $27.17From: 2005-07-26Exp: 2011-07-06→ Common Stock (30,000 underlying) - 414(indirect: By 401(k))
Common Stock
- 5,000
Employee Stock Option - Right to Buy
Exercise: $27.15From: 2005-07-26Exp: 2012-01-03→ Common Stock (5,000 underlying) - 12,500
Employee Stock Option - Right to Buy
Exercise: $27.86From: 2005-07-26Exp: 2011-07-15→ Common Stock (12,500 underlying) - 17,500
Employee Stock Option - Right to Buy
Exercise: $26.91From: 2005-07-26Exp: 2012-07-15→ Common Stock (17,500 underlying)
Footnotes (6)
- [F1]Represents shares allocated to reporting person in the MGI PHARMA, INC. Common Stock Fund of the MGI PHARMA, INC. Retirement Savings Plan in its report dated July 31, 2005. The number of shares allocated to the reporting person will vary from time to time based on the relative amounts of stock and cash held in the MGI PHARMA, INC. Common Stock Fund at the time of reporting.
- [F2]Acquisition of Restricted Stock Units, which vest in four equal annual installments beginning October 3, 2006.
- [F3]This option became immediately exercisable as of July 26, 2005, due to acceleration of vesting schedule. The option originally provided for vesting in four equal annual installments beginning on July 6, 2005. The option was also granted in tandem with a similar number of stock option appreciation rights that may be exercised only under limited circumstances following certain "change in control" events. Accordingly, the exercise of the option or the limited stock appreciation right results in the expiration of the other.
- [F4]This option became immediately exercisable as of July 26, 2005, due to acceleration of vesting schedule. The option originally provided for vesting in four equal annual installments beginning on July 15, 2005. The option was also granted in tandem with a similar number of stock option appreciation rights that may be exercised only under limited circumstances following certain "change in control" events. Accordingly, the exercise of the option or the limited stock appreciation right results in the expiration of the other.
- [F5]This option became immediately exercisable as of July 26, 2005, due to acceleration of vesting schedule. The option originally provided for vesting in four equal annual installments beginning on January 3, 2006. The option was also granted in tandem with a similar number of stock option appreciation rights that may be exercised only under limited circumstances following certain "change in control" events. Accordingly, the exercise of the option or the limited stock appreciation right results in the expiration of the other.
- [F6]This option became immediately exercisable as of July 26, 2005, due to acceleration of vesting schedule. The option originally provided for vesting in four equal annual installments beginning on July 15, 2006. The option was also granted in tandem with a similar number of stock option appreciation rights that may be exercised only under limited circumstances following certain "change in control" events. Accordingly, the exercise of the option or the limited stock appreciation right results in the expiration of the other.
Documents
Issuer
MGI PHARMA INC
CIK 0000702131
Entity typeoperating
IncorporatedMN
Related Parties
1- filerCIK 0000702131
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 11:37 AM ET
- Size
- 13.7 KB